BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lab901 Extends Screentape User Base For Rapid, Automated SDS-PAGE; Plans US Launch


3/12/2010 12:50:39 PM

Edinburgh – Mar 2010 - Lab901 announced today a significant extension of the user base for its protein ScreenTape platform for rapid, convenient, automated SDS-PAGE.

The company has completed new shipments of ScreenTape systems to ESBATech, Crucell, Symphogen, Bayer Healthcare and multiple systems to Novartis Basel.

‘We are delighted that so many premier bio-pharmaceutical companies are adding ScreenTape to their protein and antibody production workflows,’ commented Richard Rowling from Lab901. ‘The time savings and efficiency gains of completing SDS-PAGE and full analysis within minutes instead of hours, seems to be particularly important to our customers who are trying to achieve more with fewer resources,’ he added.

Lab901 recently expanded the application base for protein ScreenTape to ‘At-line’ monitoring of monoclonal antibody production and presented at the PepTalk meeting in San Diego.

‘We’ve experienced a strong demand for our protein ScreenTape system in Europe and are now generating a lot of interest in the US,’ said Joel Fearnley (CEO, Lab901). ‘The time is right to start selling ScreenTape to our biggest potential market in North America.’

The protein ScreenTape systems offer fully automated SDS-PAGE and analysis in under 1 minute per sample. Users are provided with a gel image, electropherogram and information such as molecular weight, percentage purity and quantity in a fraction of the time needed when using traditional pre-cast gel methods. Unused lanes on ScreenTape can be used for subsequent experiments making the system more cost-effective than pre-cast gels or micro-fluidic chips.

Information about ScreenTape P200 product is now available on the recently updated Lab901 website www.lab901.com

About Lab901

Lab901, based in Edinburgh, UK, is a leading laboratory automation company. The new ScreenTape P200 variant allows scientists expressing and purifying recombinant proteins and Monoclonal antibodies (MAb’s) to carry out SDS-PAGE and analysis in a fraction of the time needed for traditional gel-based or chip-based methods. Lab901 has been selling its D800 and DS12 DNA ScreenTape products into the PCR diagnostics market for the past 18 months and has now shipped over 100 systems globally. ScreenTape is manufactured at Lab901’s production facility in Loanhead, Edinburgh.

Contact: Richard Rowling +44 131 448 2904

www.lab901.com

About the ScreenTape® System:

The ScreenTape system is a fast and convenient bench top automated, platform for gel electrophoresis. Customers simply load their samples and the ScreenTape consumable into the compact TapeStation instrument and, within approx. 1 minute per sample, fully analysed results for protein, RNA and DNA samples are displayed.


Read at BioSpace.com

Lab901
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES